Brendan Strong, MBA

Brendan Strong joined Karyopharm in December 2024 as Senior Vice President, Investor Relations & Corporate Communications. He brings more than 20 years of experience in financial leadership, investor relations, corporate communications, and equity research in the healthcare field.

Most recently, Brendan served as Managing Director at Argot Partners where he advised biopharmaceutical companies on their investor relations and corporate communications strategies. Previously, Brendan led investor relations for Tenet Healthcare and also served as Chief Financial Officer of Tenet’s Massachusetts Market.  Earlier in his career, he worked in the equity research department at Lehman Brothers and Barclays and also participated in a financial leadership training program at AT&T.

Brendan earned an MBA from Harvard Business School and a B.S. in Finance from Rutgers University.